Found 469 results in Expert Content

Summary: In this webinar Endpoints Editor, John Carroll sits down with Catalent CEO, Alessandro Maselli to talk about the year ahead, offering their projections for what 2023 holds in store for the biopharma industry

Summary: In this article experts shared their insights on developing intranasal products and scaling them for commercial supply.

In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.

Summary: In this article, Mark Ignaczak provides insight into the history of nasal drug delivery and the advantages of the nasal delivery route.

Summary: In this eBook, learn more about how the timely progression of a drug candidate into clinical trials is critical for pharmaceutical companies seeking to bring new products to the market.

In this webinar experts will discuss the challenges cell and gene therapy innovators face and how experts resolve these barriers through adopting technology and strategy that drive an optimized plasmid production process and supply.

In this webinar experts will discuss a unique approach that integrates advanced formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing, statistical and regulatory support to help achieve flexible and efficient First-in-Human studies and fast development for challenging molecules.

In this webinar, experts review the definition of integrated solutions in the pharmaceutical industry, discuss the benefit and challenges of these integrated approaches and provide insights on whether integrated solutions can be the key to achieving development milestones.

This webinar will discuss challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.

In this webinar, experts will discuss a unique approach that integrates advanced formulation expertise with on-demand phase I clinical manufacturing, adaptive clinical testing, and regulatory support.